Literature DB >> 27557899

MicroRNA epigenetic signatures in human disease.

Klara Piletič1, Tanja Kunej2.   

Abstract

MicroRNAs (miRNAs) are short non-coding RNAs that act as important regulators of gene expression as part of the epigenetic machinery. In addition to posttranscriptional gene silencing by miRNAs, the epigenetic mechanisms also include DNA methylation, histone modifications and their crosstalk. Epigenetic modifications were reported to play an important role in many disease onsets and progressions and can be used to explain several features of complex diseases, such as late onset and fluctuation of symptoms. However, miRNAs not only function as a part of epigenetic machinery, but are also epigenetically modified by DNA methylation and histone modification like any other protein-coding gene. There is a strong connection between epigenome and miRNome, and any dysregulation of this complex system can result in various physiological and pathological conditions. In addition, miRNAs play an important role in toxicogenomics and may explain the relationship between toxicant exposure and tumorigenesis. The present review provides information on 63 miRNA genes shown to be epigenetically regulated in association with 21 diseases, including 11 cancer types: cardiac fibrosis, cardiovascular disease, preeclampsia, Hirschsprung's disease, rheumatoid arthritis, systemic sclerosis, systemic lupus erythematosus, temporal lobe epilepsy, autism, pulmonary fibrosis, melanoma, acute myeloid leukemia, chronic lymphocytic leukemia, colorectal, gastric, cervical, ovarian, prostate, lung, breast, and bladder cancer. The review revealed that hsa-miR-34a, hsa-miR-34b, and hsa-miR-34c are the most frequently reported epigenetically dysregulated miRNAs. There is a need to further study molecular mechanisms of various diseases to better understand the crosstalk between epigenetics and gene expression and to develop new therapeutic options and biomarkers.

Entities:  

Keywords:  Cancer; DNA methylation; Epigenetics; Histone modification; MicroRNA (miRNA); Toxicology

Mesh:

Substances:

Year:  2016        PMID: 27557899     DOI: 10.1007/s00204-016-1815-7

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  88 in total

Review 1.  From genetics to epigenetics: new insights into keloid scarring.

Authors:  Yongjing He; Zhenjun Deng; Mansour Alghamdi; Lechun Lu; Mark W Fear; Li He
Journal:  Cell Prolif       Date:  2017-01-05       Impact factor: 6.831

Review 2.  A network-biology perspective of microRNA function and dysfunction in cancer.

Authors:  Cameron P Bracken; Hamish S Scott; Gregory J Goodall
Journal:  Nat Rev Genet       Date:  2016-10-31       Impact factor: 53.242

3.  MiR-16-1 Targeted Silences Far Upstream Element Binding Protein 1 to Advance the Chemosensitivity to Adriamycin in Gastric Cancer.

Authors:  Danyi Zhao; Yang Zhang; Lei Song
Journal:  Pathol Oncol Res       Date:  2017-06-30       Impact factor: 3.201

Review 4.  Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis.

Authors:  Xia Hao; Lingzi Xia; Ruoyi Qu; Xianglin Yang; Min Jiang; Baosen Zhou
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

5.  Clinical Relevance of microRNA Expressions in Breast Cancer Validated Using the Cancer Genome Atlas (TCGA).

Authors:  Sara Y Kim; Tsutomu Kawaguchi; Li Yan; Jessica Young; Qianya Qi; Kazuaki Takabe
Journal:  Ann Surg Oncol       Date:  2017-08-01       Impact factor: 5.344

6.  Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells.

Authors:  Ravneet Chhabra; Stephanie Rockfield; Jennifer Guergues; Owen W Nadeau; Robert Hill; Stanley M Stevens; Meera Nanjundan
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

Review 7.  The emerging field of epigenetics in neurodegeneration and neuroprotection.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

8.  Analysis of the function of microRNA-375 in humans using bioinformatics.

Authors:  Xiaohua Chen; Baoxia Li; Rongcheng Luo; Sina Cai; Cao Zhang; Xiaolong Cao
Journal:  Biomed Rep       Date:  2017-04-10

9.  The risk of leukemia in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Xiao Luo; Yue He; Wangdong Xu; Mao Liu; Zixia Zhao; Lihui Peng; Chengsong He; Jie Chen
Journal:  Clin Rheumatol       Date:  2020-09-17       Impact factor: 2.980

Review 10.  Epigenetic dynamics in cancer stem cell dormancy.

Authors:  Alejandra I Ferrer; Jonathan R Trinidad; Oleta Sandiford; Jean-Pierre Etchegaray; Pranela Rameshwar
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.